Skip to main content
Quest Diagnostics

Changes in Test Volumes During Coronavirus Disease 2019 (COVID-19): A Laboratory Stewardship Opportunity

Changes in Test Volumes During Coronavirus Disease 2019 (COVID-19): A Laboratory Stewardship Opportunity

Authors: Ila R Singh, Michael Dowlin, Thomas H Chong, Jon M Nakamoto, Lee H Hilborne

Citation: Arch Pathol Lab Med 2021 Mar 25. doi: 10.5858/arpa.2021-0058-SA. Online ahead of print.

Specialties: Infectious disease, COVID-19

Download key summary

Related content

Publication
Assessing vulnerability to COVID 19 in high risk populations: the role of SARS CoV 2 spike targeted serology
Publication
Comparison of SARS-CoV-2 RT-PCR Ct values across multiple assays with different targets
Publication
SARS-CoV-2 Spike-Protein Targeted Serology Test Results and Their Association With Subsequent COVID-19-Related Outcomes
Test FAQ
SARS CoV 2 Antibody Testing
Publication
Strategies for laboratory professionals to drive laboratory stewardship
On-Demand Webinar
How to Close Gaps in Care by Maximizing the Power of Laboratory Stewardship Solutions

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.